DOUBLE-BLIND STUDY in Croatian translation

A double-blind study was carried out in 209 subjects who were randomly allocated to two groups A and B.

U ovu dvostruko-slijepu studiju bilo je ukljueno 209 bolesnika koji su nasumce podijeljeni u dvije skupine A i B.

A further multinational double-blind study(SP889) was conducted in 287 patients with early

Sljedeće multinacionalno, dvostruko-slijepo ispitivanje(SP889) uključilo je 287 bolesnika u ranom

In the double-blind study SP515, 201 patients received rotigotine,

U dvostruko-slijepom ispitivanju SP515 201 bolesnik primao je rotigotin,

Only one death occurred in each treatment group during the 6-month double-blind study period, therefore no conclusion can be drawn on survival.

Došlo je do jednog smrtnog slučaja u svakoj skupini tijekom šestomjesečne dvostruko slijepe studije pa se ne može donijeti zaključak o utjecaju na preživljenje.

In a randomized, double-blind study, patients with 40% overall body area burns were chosen to get conventional burn treatment plus oxandrolone, or without oxandrolone.

U randomiziranom, dvostruko slijepom istraživanju, bolesnici s 40% u ukupnom poretku tjelesne površine opeklina, odabrani su kako bi dobili zajedničku brigu topljenju plus oxandrolone, ili bez oxandrolone.

In a randomized, double-blind study, clients with 40% complete body surface area burns were selected to receive basic melt care plus oxandrolone, or without oxandrolone.

In a randomized, double-blind study, patients with 40% overall body surface area burns were selected to receive standard shed care plus oxandrolone, or without oxandrolone.

The double-blind study population comprised 409 patients of whom 272 received Xiapex 0.58 mg and 137 received placebo.

Populacija u dvostruko slijepim ispitivanjima sastojala se od 409 bolesnika od kojih je 272 primilo 0, 58 mg Xiapexa, a 137 placebo.

The double-blind study population comprised 832 male patients of whom 551 patients received Xiapex and 281 received placebo.

Populacija u dvostruko slijepim ispitivanjima sastojala se od 832 muška bolesnika od kojih je 551 bolesnik primio Xiapex, a 281 placebo.

A small(n 83), Phase II, randomised, double-blind study in patients receiving chemotherapy for de novo acute myeloid leukaemia compared pegfilgrastim(single dose of 6 mg)

U malom(n 83), randomiziranom, dvostruko slijepom ispitivanju faze II, u bolesnika s de novo akutnom mijeloičnom leukemijom liječenih kemoterapijom uspoređivan je pegfilgrastim(pojedinačna doza od 6 mg)

In a double-blind study in patients with idiopathic pulmonary fibrosis,

U dvostruko slijepom ispitivanju bolesnika s idiopatskom plućnom fibrozom(IPF),

A further randomised, multicentre, double-blind study was conducted to compare the efficacy of NeuroBloc(10,000 U)

Sljedeće randomizirano, multicentrično, dvostruko slijepo ispitivanje provedeno je kako bi se usporedila djelotvornost NeuroBloca(10 000 U)

In a double-blind study in patients with PAH, macitentan 10 mg

U dvostruko slijepom ispitivanju u bolesnika s PAH-om,

A phase II, randomised double-blind study of two dose levels(200 mg or 800 mg once daily)

Randomizirano, dvostruko slijepo ispitivanje faze II dviju razina doze(200 mg ili 800 mg jedanput na dan)

In a double-blind study in patients with PAH, macitentan 10 mg

U dvostruko slijepom ispitivanju u bolesnika s PAH-om,

In a randomised, double-blind study with a total of 667 patients receiving highly emetogenic chemotherapy that included cisplatin≥ 60 mg/m2,

U randomiziranom, dvostruko slijepom ispitivanju na ukupno 667 bolesnika na visoko emetogenoj kemoterapiji koja je uključivala cisplatin ≥60 mg/m2,

randomised, double-blind study that compared caffeine citrate to placebo in 85 preterm infants(gestational age 28 to< 33 weeks) with apnoea of prematurity.

randomiziranom, dvostruko slijepom ispitivanju u kojem se kofeincitrat uspoređivao s placebom u 85-ero nedonoščadi(gestacijska dob 28 do< 33 tjedna) s apnejom nedonoščeta.

The effects of AVONEX in the treatment of MS were also demonstrated in a randomised double-blind study performed with 383 patients(AVONEX n=193,

Učinci AVONEXA u liječenju MS-e također su bili prikazani u nasumičnom i dvostruko slijepom ispitivanju provedenom na 383 bolesnika(AVONEX n=193,

randomised, double-blind study in 46 paediatric patients(6 to 17 years old)

randomiziranom, dvostruko slijepom ispitivanju koje je uključivalo 46 pedijatrijskih bolesnika(u dobi od 6 do 17 godina)

The incidence of aminotransferase elevations(ALT/AST)> 3× ULN was 3.4% on macitentan 10 mg and 4.5% on placebo in a double-blind study in patients with PAH.

Incidencija povišenja aminotransferaza(ALT/AST)> 3 × GGN iznosila je 3,4% za skupinu koja je primala macitentan 10 mg i 4,5% za skupinu koja je primala placebo u dvostruko slijepom ispitivanju u bolesnika s PAH-om.